Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,735 public trials 964 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

NCT00385580

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University Of Chicago Chicago, Illinois, United States
  • The Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States
  • Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center New York, United States
View Trial Details
Completed

Early Stage Prostate Cancer Cohort

NCT00011349

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States
  • VA Medical Center, Long Beach Long Beach, California, United States
  • VA Medical Center, DC Washington D.C., District of Columbia, United States
  • James A. Haley Veterans Hospital, Tampa Tampa, Florida, United States
View all 13 locations
View Trial Details
Completed

A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01017939

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Beverly Hills, California, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • San Antonio, Texas, United States
View Trial Details
Completed

A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT00910754

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Buffalo, New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
  • Myrtle Beach, South Carolina, United States
View Trial Details
Completed

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

NCT00313781

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site New York, United States
  • Pfizer Investigational Site Cleveland, Ohio, United States
  • Pfizer Investigational Site Cleveland, Ohio, United States
View all 18 locations
View Trial Details

Related conditions